Theriva Biologics, Inc. (TOVX) › Net IncomeTheriva Biologics, Inc. (TOVX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: -$17.07M2013: -$12.32M2014: -$19.78M2015: -$44.78M2016: -$27.80M2017: -$15.49M2018: -$13.42M2019: -$15.38M2020: -$10.12M2021: -$14.27M2022: -$19.68M2023: -$18.35M2024: -$25.65M2025: -$23.74M-$23.74M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$23.74M+7.5%2024-$25.65M-39.8%2023-$18.35M+6.8%2022-$19.68M-38.0%2021-$14.27M-41.0%2020-$10.12M+34.2%2019-$15.38M-14.6%2018-$13.42M+13.4%2017-$15.49M+44.3%2016-$27.80M+37.9%2015-$44.78M-126.4%2014-$19.78M-60.6%2013-$12.32M+27.8%2012-$17.07M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share